92 related articles for article (PubMed ID: 9871658)
1. Methyloxime-substituted aminopyrrolidine: a new surrogate for 7-basic group of quinolone.
Hong CY; Kim YK; Lee YH; Kwak JH
Bioorg Med Chem Lett; 1998 Feb; 8(3):221-6. PubMed ID: 9871658
[TBL] [Abstract][Full Text] [Related]
2. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
Odžak R; Skočibušić M; Maravić A
Bioorg Med Chem; 2013 Dec; 21(23):7499-506. PubMed ID: 24126094
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro and in vivo evaluation of quinolones with selective activity against gram-positive organisms.
Cooper CS; Klock PL; Chu DT; Hardy DJ; Swanson RN; Plattner JJ
J Med Chem; 1992 Apr; 35(8):1392-8. PubMed ID: 1573632
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antibacterial, and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives.
Fang KC; Chen YL; Sheu JY; Wang TC; Tzeng CC
J Med Chem; 2000 Oct; 43(20):3809-12. PubMed ID: 11020298
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of novel 7-(3-substituted-3 or 4-trifluoromethyl-1-pyrrolidinyl)-8-methoxyfluoroquinolones.
Fukui H; Shibata T; Naito T; Nakano J; Maejima T; Senda H; Iwatani W; Tatsumi Y; Suda M; Arika T
Bioorg Med Chem Lett; 1998 Oct; 8(20):2833-8. PubMed ID: 9873632
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Antimicrobial Activity and Molecular Docking Study of Novel α-(Diphenylphosphoryl)- and α-(Diphenylphosphorothioyl)cycloalkanone Oximes.
Jebli N; Hamimed S; Van Hecke K; Cavalier JF; Touil S
Chem Biodivers; 2020 Aug; 17(8):e2000217. PubMed ID: 32421207
[TBL] [Abstract][Full Text] [Related]
8. [In vitro and in vivo antibacterial activities of a new quinolone derivative, FD501].
Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
Jpn J Antibiot; 1996 Mar; 49(3):264-72. PubMed ID: 8935122
[TBL] [Abstract][Full Text] [Related]
9. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
11. Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives.
Bouzard D; Di Cesare P; Essiz M; Jacquet JP; Kiechel JR; Remuzon P; Weber A; Oki T; Masuyoshi M; Kessler RE
J Med Chem; 1990 May; 33(5):1344-52. PubMed ID: 2329555
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activity of thiazolopyrazine-incorporated tetracyclic quinolone antibacterial agents. 2.
Jinbo Y; Kondo H; Taguchi M; Inoue Y; Sakamoto F; Tsukamoto G
J Med Chem; 1994 Aug; 37(17):2791-6. PubMed ID: 8064806
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Biological Evaluation of New Piperazin-4-yl-(acetyl-thiazolidine-2,4-dione) Norfloxacin Analogues as Antimicrobial Agents.
Marc G; Araniciu C; Oniga SD; Vlase L; Pîrnău A; Nadăș GC; Novac CȘ; Matei IA; Chifiriuc MC; Măruțescu L; Oniga O
Molecules; 2019 Oct; 24(21):. PubMed ID: 31683749
[No Abstract] [Full Text] [Related]
14. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
[TBL] [Abstract][Full Text] [Related]
15. 1-Chloropiperazinic derivative (ER 311) of norfloxacin: antibacterial activity in vitro and pharmacokinetic properties in mice.
Dubini F; Balsari A; Stradi R; Riviera L
Chemioterapia; 1987 Jun; 6(2 Suppl):178-80. PubMed ID: 3509385
[No Abstract] [Full Text] [Related]
16. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
[TBL] [Abstract][Full Text] [Related]
17. The chemistry and biological profile of trovafloxacin.
Brighty KE; Gootz TD
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():1-14. PubMed ID: 9222064
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates.
Cunha BA; Qadri SM; Ueno Y; Walters EA; Domenico P
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity and pharmacokinetics in mice of two new derivatives of norfloxacin.
Balsari A; Dubini F; Stradi R; Riviera L
Chemioterapia; 1987 Jun; 6(2 Suppl):176-8. PubMed ID: 3509384
[No Abstract] [Full Text] [Related]
20. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
